Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F65C6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,374
Award facts
- Contract value 100% obligated
- $11,374.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,374.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Gemtesa 75 mg on January 7, 2026, with an ultimate completion date of January 8, 2026. The contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant indefinite delivery contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 2026, serving as the primary vehicle for pharmaceutical and medical supply procurement to support military healthcare programs globally.
Gemtesa is a prescription medication used in the treatment of overactive bladder, and this order represents a routine pharmaceutical supply delivery to support federal military healthcare requirements. AmerisourceBergen functions as a critical pharmaceutical distributor and healthcare solutions provider within the federal medical procurement system, with demonstrated capability to fulfill competitive federal procurement requirements across a broad spectrum of therapeutic domains including specialty medications, vaccines, and medical devices. The delivery order structure with firm fixed pricing reflects standard federal pharmaceutical procurement practices through the DLA's comprehensive medical supply chain network.
Quick answers
Who was awarded contract SPE2DR26F65C6?
SPE2DR26F65C6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F65C6 worth?
The government has obligated $11,374 on SPE2DR26F65C6.
Is contract SPE2DR26F65C6 an order under another contract?
Yes. SPE2DR26F65C6 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65C6 competed?
The extent of competition for SPE2DR26F65C6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award